VBILX | VBMFX | VBILX / VBMFX | |
Total Expense Ratio | 0.06 | 0.15 | 40% |
Annual Report Gross Expense Ratio | 0.06 | 0.15 | 40% |
Fund Existence | 24 years | 38 years | - |
Gain YTD | 1.631 | 0.422 | 386% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 3000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 44.8B | 353B | 13% |
Annual Yield % from dividends | 3.82 | 3.62 | 106% |
Returns for 1 year | 2.03 | 0.63 | 321% |
Returns for 3 years | -3.48 | -5.16 | 68% |
Returns for 5 years | -16.93 | -17.25 | 98% |
Returns for 10 years | -0.89 | -10.63 | 8% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CWVGX | 24.81 | N/A | N/A |
Calvert International Equity A | |||
BIPSX | 19.71 | N/A | N/A |
ProFunds Biotechnology UltraSector Svc | |||
JVLAX | 24.44 | N/A | N/A |
JHancock Disciplined Value A | |||
MGOYX | 12.77 | N/A | N/A |
Victory Munder Mid-Cap Core Growth Y | |||
BBHLX | 19.25 | -0.10 | -0.52% |
BBH Partner Fund - International Eq I |